Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The name change does nothing on re-registering shares. It’s just a table entry update to associate the shares to the new identifying information.
Yes indeed. Buckle up boomer!
I tend to think the impetus behind some of this Populist ideology expressed by these Wall Street Bet participants has to do with the jealousy of the elites in American society.
Yes, and the profound depth of that sentiment is what causes me to think that we are witnessing something that this market is not prepared to cope with.
Thanks for that link. That thread is eye-opening. Between the passion exhibited on that board, and the copious amounts of virtue signaling to come by pols and celebs, I truly believe the SEC will be forced to shut it down on Monday.
I don't understand how a stock can be oversold to the extent of 140% of the float, maybe it has something to do with options.
I see a class action lawsuit has been filed against Robinhood for restricting buys. But now that it is common knowledge that 140% of the float is already sold short, how do you sue the brokers to keep selling something that they know does not exist, or should reasonably know does not exist?
The SEC should have stepped in as soon as the oversold position came to light.
No place to talk? This is a CMKX board, and we could all use some entertainment.
Serious question, which of the previous two posts contains the most useful information?
No, it is not so.
In the words of Ayn Rand - Contradictions do not exist. Whenever you think you are facing a contradiction, check your premises. You will find that one of them is wrong.
BP killer? BP killers become BP's biggest earners.
The question is, how has Leo managed to keep Brilacidin off of BP's radar?
Hmm, all of the pros were for the company, officers and directors. All of the cons refer to the shareholders.
Historical Short Volume data for October:
Historical Short Volume Data for PTOI
Date Close High Low Volume Sht Vol % of Vol Shtd
Oct 13 NA NA NA NA NA NA
Oct 12 NA NA NA NA NA NA
Oct 07 NA NA NA NA NA NA
Oct 06 NA NA NA NA NA NA
Oct 02 NA NA NA NA NA NA
Oct 01 NA NA NA NA NA NA
Sorry about the formatting, I think you get the gist.
If the "some one" is a retail buyer, and you are a retail seller, then I disagree. Not only is it not crazy, it is how this market is designed to work.
It is crazy because *If I want to sell some Ipix I will not ask for less money than some one just pay moment before.*
Crazy why? If that was a Jeopardy answer, the question would be - "What is the Spread, Alex."
Yes it is crazy. If I want to sell some Ipix I will ask for less money than some one just pay moment before? This shit will change soon.
14 commas, and zero periods? Go on, finish your thought.
So that's your thing, big shot Bradley, sending nasty childish private messages, that are the same kind of communication I would expect coming from some punk kid that owns nothing,but rents the trailer in his parents backyard, you sure write as if you come from some kind of a failure environment, far from being or acting like an adult, just some guy who can't get anyone to pay attention to him,
by the way I own the four bedroom house above my basement, with 0 mortgage payments due, something you are most likely a life time away from, l also took screenshots of all your nasty post attacks, and also from your other handle C Cap, just so there is proof of your nasty attack reply Post's, since I work with many in the legal industry, I would think twice about replying
No need for the Feds, it's already been investigated by the SEC -
https://ih.advfn.com/stock-market/USOTC/innovation-pharmaceuticals-qb-IPIX/stock-news/82994799/prospectus-filed-pursuant-to-rule-424b5-424b5
Hmmm, I wan't around back then. Why don't we re-visit the Mako post and see how it stands up to the test of time?
I've been around here since April 2013 and the only leak I can remember was the evil nefarious one, just before Mako.
Excellent analysis! We're lucky to have someone on the board who has chased these nefarious criminals for the last 17 years.
An interesting coincidence at the very least. What we know for sure is that Levinston lost a quarter of a million bucks today.
Smart move by Leo to dust off the old shelf offering since the market cap is over the magical $75 million at FYE.
IPIX outstanding = 320,494,884
16,666,734/.052
Leviston Resources LLC 13-G filed 5.2%
Hmm, you should start with the obvious. Any options vested recently?
What's with the price hike, volume increase and all those blue lines on the chart from mid-day Friday? Something brewing?
Now that's impressive!
""it will go away with warmer weather"? Well, THAT ain't happening, and it's plenty warm!"
Hmmm, I guess you're human after all. This seems to be the most relevant section of the MFO agreement for the last 5 days:
Limitations on Conversion and Issuance
The Series B preferred stock may not be converted and shares of our common stock may not be issued under the Certificate of Designation with respect to such Series B preferred stock if, after giving effect to the conversion or issuance, a holder together with its affiliates would beneficially own in excess of 9.99% of the outstanding shares of our common stock.
The holders of the Series B preferred stock are limited in the amount of stated value of the Series B preferred stock they can convert on any trading day. The conversion cap limits conversions by the holders to the greater of $75,000 and an amount equal to 30% of the aggregate dollar trading volume of our common stock on our primary trading market for the five trading days immediately preceding, and including, the conversion date. However, the conversion cap will be increased if the trading volume in the first 30 minutes of any trading session exceeds certain trailing average daily volume amounts.
Au contaire, the share price opened and closed in the .15's as recent as June 16. I believe the 85% of lowest VWAP in last 10 trading days prior to and ending on today is still in play.
It's impossible to get a handle on the CURRENT status of the mfo's preferred holdings, but for the last 5 days the conversion price for them has been calculated differently than it was during the previous 20 months.
“We now have preliminary in vitro data from two separate independent laboratories that, cumulatively, support Brilacidin’s ability to act directly on the novel coronavirus, as a virucidal agent, and prevent viral binding to host cells.“
What effect does the word "cumulatively" have on the statement above? Does it mean that the two tests individually do not support..., but cumulatively, the two tests do support...?
Over 500 posts on 229 different stock boards so far in the month of May. And the only thing I can tell is that you were burned bad by a company called MyECheck, Inc. You appear to be an oddity with neither rhyme nor reason.
Oh well, my curiosity is no longer piqued.
Fun facts from the 10Q:
1. MFO exercises warrants to buy preferred at a discount to stated value (cash is raised). Proceeds from the exercise of warrants $1,490,000
2. Preferred is converted to common at a second discount (no cash is raised). 2,884 preferred were converted into 48,197,729 common
The FDA didn't name companies. The names came from Financialnewsmedia.com. Those companies all have news releases on their site.
Not a single lie in that press release.
Press releases are an art form, and Leo has truly mastered the art of the press release. If you deduced something from that press release that turns out not to be the case, that's a "you" problem. Happy Friday. :)
It's very likely the orders settled lower were sell-orders, not buy-orders like yours. Here's a link to the process from OTC markets.
https://www.otcmarkets.com/learn/market-101/trading
No restrictions? You put a market order in and it still didn't get filled?
Filling below by bid with no restrictions on my trades, such BS.
Thanks for playing your part Alan, this stock is a trader's dream.
Whatever you do, don't read FINRA Information Notice 5/10/19.
https://www.finra.org/rules-guidance/notices/information-notice-051019
According to you, the system is useless.
Keep in mind that John is the only one who can make that system work as he designed it. If John isn't there the system is useless so if one the brainchildren here want to buy it go ahead. But you're buying something that you can't make work.
I think the "why" is self evident. Demand and share price were rising, and the MFO was able to convert at a very favorable vwap from a couple weeks ago. I think the timeline between purchase of preferreds to conversion and sale of common in the market is hours, not days. (And I wouldn't be surprised if they happen practically simultaneously.)
I couldn't and still can't connect the dots that explain why the MFO would have accelerated its purchase of Preferred (providing funding) and how that could be connected to the common share volume in the market using the known data.
Hope you can get all you can eat daddy.
Why does that not surprise me in the least?
JBI RE#1 Inc was a wholly owned subsidiary of JBI,Inc per the 2009 10K:
On February 4, 2010, the Company formed a wholly owned New York corporation, JBI RE #1, Inc. to purchase an industrial building containing 14,860 square feet that is situated on about 3.37 acres of land in Niagara Falls, NY. This entity will house the first commercial operation of Plastic2Oil (“P2O”).
No sure if that is still the case. My thinking is Plastic2Oil of NY #1, LLC is Heddle's entity. Does Heddle now own the patent application?
JBI RE#1 Inc shows as active.
NYS Department of State
Division of Corporations
Entity Information
The information contained in this database is current through February 19, 2020.
Selected Entity Name: JBI RE #1, INC.
Selected Entity Status Information Current Entity Name: JBI RE #1, INC.
DOS ID #: 3908486
Initial DOS Filing Date: FEBRUARY 04, 2010
County: NIAGARA
Jurisdiction: NEW YORK
Entity Type: DOMESTIC BUSINESS CORPORATION
Current Entity Status: ACTIVE
Selected Entity Address Information DOS Process (Address to which DOS will mail process if accepted on behalf of the entity)
JBI RE #1, INC.
C/O CANNON HEYMAN & WEISS, LLP
726 EXCHANGE STREET, STE 516
BUFFALO, NEW YORK, 14210
Registered Agent
NONE
Have you ever wondered why the PTOI short interest seems so low when you compare it to the PTOI short sales that get reported on a daily basis? Turns out that those daily short reports don't show all of the information. That's why there is no correlation between the short sales reported daily, and the actual short interest that is reported twice a month. FINRA explains it all here https://www.finra.org/rules-guidance/notices/information-notice-051019 .
However, the daily report is not totally useless, and if you watch it long enough patterns start to appear. Here is something I've noticed from watching for many years. If the short percentage reported is say 30% or more, it tells me that the market maker has a willing seller that he is working with. The higher the percentage, the bigger the seller.
The company mentions the $400K per month in the 8K filed 5/10/19. The MFO was compelled to exercise that amount for a period of 5 months. However, I share your opinion that the MFO has continued to exercise a significant amount of warrants (and sold the shares into the market) up to this point in time.
Item 1.01 Entry into a Material Definitive Agreement.
On May 9, 2019, Innovation Pharmaceuticals Inc. (the “Company”) entered into a Warrant Restructuring and Additional Issuance Agreement (the “Issuance Agreement”) with the holders (the “Series B investors”) of the Company’s Series B 5% convertible preferred stock (the “preferred stock”) and warrants to purchase preferred stock (the “existing warrants”). Pursuant to the Issuance Agreement, the Series B investors have agreed, subject to the conditions set forth therein, to exercise existing warrants to purchase 500 shares of preferred stock following execution of the Issuance Agreement, and to amend the existing warrants to permit the Company to compel the exercise of up to $400,000 of existing warrants each calendar month commencing June 3, 2019 and ending November 1, 2019, or, if earlier, until the aggregate amount of the forced exercises is $2,000,000. As consideration for the Series B investors entering into the Issuance Agreement, the Company has issued 100 shares of preferred stock and warrants to purchase 2,500 shares of preferred stock (the “series 4 warrants”) to the Series B investors. In addition, the Company extended the termination date for the series 1 warrants issued in October 2018 by six months, and has agreed to issue one additional share of preferred stock to the Series B investors for each five shares issued upon the exercise of the existing warrants or series 4 warrants through November 9, 2019, up to a maximum of 400 shares of preferred stock.
https://ih.advfn.com/stock-market/USOTC/innovation-pharmaceuticals-qb-IPIX/stock-news/79886975/current-report-filing-8-k